[Progress in researches on drugs for prostate cancer].
In the recent years, researches on drugs for prostate cancer have received more attention than ever before. This article reviews the mechanism and efficacy of such prostate cancer drugs as bicalutamide, medroxyprogesterone acetate, megestrol acetate, flutamide and so on, as well as the clinical data and clinical uses of calcitriol analogue EB1089, SR233377, etc.
Cao
Ling-Yan
LY
Department of Pharmaceutic Products, Nanjing General Hospital of Nanjing Command, PLA, Nanjing, Jiangsu 210002, China.
Huang
He
H
Ni
Jiang-Hong
JH
D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D013498:Suramin / Q000627:therapeutic use; D013892:Thioxanthenes / Q000627:therapeutic use
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D013449:Sulfonamides; D013892:Thioxanthenes; D017273:Goserelin; C096974:WIN 33377; D013498:Suramin